Paul V Maier - Net Worth and Insider Trading
Paul V Maier Net Worth
The estimated net worth of Paul V Maier is at least $2 Million dollars as of 2024-11-13. Paul V Maier is the Sr. V-P, CFO of Ligand Pharmaceuticals Inc and owns about 14,159 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $2 Million. Paul V Maier is the Director of Eton Pharmaceuticals Inc and owns about 59,745 shares of Eton Pharmaceuticals Inc (ETON) stock worth over $546,667. Paul V Maier is also the CFO of Sequenom Inc and owns about 63,111 shares of Sequenom Inc (SQNM) stock worth over $150,835. Besides these, Paul V Maier also holds International Stem Cell Corp (ISCO) , MabVax Therapeutics Holdings Inc (MBVXQ) . Details can be seen in Paul V Maier's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul V Maier has not made any transactions after 2019-04-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul V Maier
Paul V Maier Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul V Maier owns 10 companies in total, including International Stem Cell Corp (ISCO) , Eton Pharmaceuticals Inc (ETON) , and Ritter Pharmaceuticals Inc (RTTR) among others .
Click here to see the complete history of Paul V Maier’s form 4 insider trades.
Insider Ownership Summary of Paul V Maier
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ISCO | International Stem Cell Corp | 2019-04-18 | director |
| ETON | Eton Pharmaceuticals Inc | 2018-11-15 | director |
| RTTR | Ritter Pharmaceuticals Inc | 2020-01-15 | director |
 | | 2018-04-02 | director |
| | 2014-01-02 | director |
| | 2014-02-10 | Chief Financial Officer |
| | 2008-01-22 | director |
| | 2006-11-20 | Sr. V-P & CFO |
| | 2015-06-24 | director |
| | 2023-06-07 | director |
Paul V Maier Latest Holdings Summary
Paul V Maier currently owns a total of 5 stocks. Among these stocks, Paul V Maier owns 14,159 shares of Ligand Pharmaceuticals Inc (LGND) as of November 20, 2006, with a value of $2 Million and a weighting of 70.97%. Paul V Maier owns 59,745 shares of Eton Pharmaceuticals Inc (ETON) as of November 15, 2018, with a value of $546,667 and a weighting of 22.69%. Paul V Maier also owns 63,111 shares of Sequenom Inc (SQNM) as of August 1, 2012, with a value of $150,835 and a weighting of 6.26%. The other 2 stocks International Stem Cell Corp (ISCO) , MabVax Therapeutics Holdings Inc (MBVXQ) have a combined weighting of 0.08% among all his current holdings.
Latest Holdings of Paul V Maier
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2006-11-20 | 14,159 | 120.74 | 1,709,558 |
| ETON | Eton Pharmaceuticals Inc | 2018-11-15 | 59,745 | 9.15 | 546,667 |
| SQNM | Sequenom Inc | 2012-08-01 | 63,111 | 2.39 | 150,835 |
| ISCO | International Stem Cell Corp | 2019-04-18 | 31,710 | 0.06 | 1,906 |
| MBVXQ | MabVax Therapeutics Holdings Inc | 2015-05-29 | 225 | 0.02 | 5 |
Holding Weightings of Paul V Maier
Paul V Maier Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul V Maier has made a total of 0 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 4,503 shares on November 20, 2006, which brought Paul V Maier around $308,793.
According to the SEC Form 4 filings, Paul V Maier has made a total of 0 transactions in Eton Pharmaceuticals Inc (ETON) over the past 5 years. The most-recent trade in Eton Pharmaceuticals Inc is the acquisition of 5,000 shares on November 15, 2018, which cost Paul V Maier around $30,000.
According to the SEC Form 4 filings, Paul V Maier has made a total of 0 transactions in Sequenom Inc (SQNM) over the past 5 years. The most-recent trade in Sequenom Inc is the acquisition of 10,000 shares on August 1, 2012, which cost Paul V Maier around $28,600.
More details on Paul V Maier's insider transactions can be found in the Insider Trading History of Paul V Maier table.Insider Trading History of Paul V Maier
- 1
Paul V Maier Trading Performance
GuruFocus tracks the stock performance after each of Paul V Maier's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul V Maier is -0.92%. GuruFocus also compares Paul V Maier's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul V Maier within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul V Maier's insider trading performs compared to the benchmark.
Performance of Paul V Maier
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.62 | | | | | |
| Relative Return to S&P 500(%) | 11.24 | | | | | |
Paul V Maier Ownership Network
Ownership Network List of Paul V Maier
Ownership Network Relation of Paul V Maier
Paul V Maier Owned Company Details
What does International Stem Cell Corp do?
Who are the key executives at International Stem Cell Corp?
Paul V Maier is the director of International Stem Cell Corp. Other key executives at International Stem Cell Corp include 10 percent owner Andrei Semechkin , Dir. of Legal Affairs & Oper. Sofya Bakalova , and Acting Chief Financial Officer Jennifer Stephens .
International Stem Cell Corp (ISCO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of International Stem Cell Corp (ISCO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of International Stem Cell Corp (ISCO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
International Stem Cell Corp (ISCO)'s detailed insider trading history can be found in Insider Trading Tracker table.
International Stem Cell Corp Insider Transactions
Paul V Maier Mailing Address
Above is the net worth, insider trading, and ownership report for Paul V Maier. You might contact Paul V Maier via mailing address: 3595 John Hopkins Court, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
